Press Releases

SOLCO HEALTHCARE US, RECEIVES FDA APPROVAL FOR GLYCOPYRROLATE INJECTION, 0.2 mg/mL

Mar 08, 2019 04:21

March 8, 2018 SOLCO HEALTHCARE US, RECEIVES FDA APPROVAL FOR GLYCOPYRROLATE INJECTION, 0.2 mg/mL CRANBURY, NJ -- Solco Healthcare announces its FDA approval for Glycopyrrolate Injection, 0.2mg/mL, which is an...

Read more

SOLCO HEALTHCARE US ANNOUNCES THE FDA APPROVAL OF FENOFIBRATE TABLETS, 48mg and 145mg

Mar 08, 2019 04:05

CRANBURY, NJ -- Solco Healthcare is proud to announce its FDA approval for Fenofibrate tablets, 48 mg and 145 mg, which is an AB-rated equivalent to Tricor® by Abbvie. Fenofibrate...

Read more

Manager/Senior Manager, Order to Cash

Feb 27, 2019 15:51

COMPANY BACKGROUND Solco Healthcare U.S., headquartered in Cranbury, New Jersey, is an industry leader in marketing and distributing generic pharmaceuticals. Solco is committed to providing our customers with high...

Read more

Solco News

Here you will find useful healthcare related information and latest industry news, including exclusive content available only on Solco News.


Archives

2019 2018 2017 2016